1.
Bioorg Med Chem Lett
; 16(16): 4287-90, 2006 Aug 15.
Article
in English
| MEDLINE
| ID: mdl-16753296
ABSTRACT
Starting with the weak agonist indomethacin, a series of potent, selective CRTh2 (DP(2)) antagonists have been discovered as potential treatments for asthma, allergic rhinitis and other inflammatory diseases.